Side effects and the need for secrecy: characterising discontinuation of modern contraception and its causes in Ethiopia using mixed methods
Tóm tắt
Contraceptive discontinuation is a major barrier to reducing global unmet needs for family planning, but the reasons why women discontinue contraception are poorly understood. Here we use data from Ethiopia to investigate (i) the magnitude of contraceptive discontinuation in 2005–2011, (ii) how the risk of discontinuation varies with method type and education level and (iii) the barriers to continuation. Our main hypothesis is that contraceptive discontinuation is driven by the experience of physiological side-effects associated with the use of hormonal contraception, rather than a lack of formal education. We used a mixed methods explanatory sequential design to explain the quantitative results in more details through the qualitative data. First, we analysed quantitative data from the 2011 Ethiopian Demographic and Health Survey to study patterns of contraceptive discontinuation and method choice using multilevel multiprocess models. Second, we conducted semi-structured interviews and focus group discussions in the 3 most populated regions of Ethiopia with individuals of reproductive age and health professionals. The analysis of EDHS data shows that the rate of discontinuation has not reduced in the period 2005–2011 and remains high. Discontinuation mainly takes the form of abandonment, and is a function of method type, age and wealth but not of educational level. Interviews with women and health professionals reveal that the experience of debilitating physiological side effects, the need for secrecy and poverty are important barriers to continuation. Our findings together suggest that physiological and social side-effects of contraceptive use, not a lack of formal education, are the root causes of contraceptive abandonment in Ethiopia.
Tài liệu tham khảo
Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet. 2012;380:111–25.
Singh S, Darroch JE. Adding it up: costs and benefits of contraceptive services estimates for 2012. 2012.
Canning D, Schultz TP. The economic consequences of reproductive health and family planning. Lancet. 2012;380:165–71. https://doi.org/10.1016/S0140-6736(12)60827-7.
Jacobstein R, Curtis C, Spieler J, Radloff S. Meeting the need for modern contraception: effective solutions to a pressing global challenge. Int J Gynaecol Obstet. 2013;121(Suppl 1):S9–15. doi:10.1016/j.ijgo.2013.02.005. Epub 2013 Mar 6.
Wulifan JK, Brenner S, Jahn A, De Allegri M. A scoping review on determinants of unmet need for family planning among women of reproductive age in low and middle income countries. BMC Womens Health. 2015;16:2. https://doi.org/10.1186/s12905-015-0281-3.
FP2020. Family Planning 2020. http://www.familyplanning2020.org/. Accessed 21 Feb 2017.
Ali MM, Cleland J. Oral contraceptive discontinuation and its aftermath in 19 developing countries. Contraception. 2010;81:22–9.
Ali MM, Cleland J, Shah IH. Causes and consequences of contraceptive discontinuation: evidence from 60 demographic and health surveys. 2012.
Castle S, Askew I. Contraceptive discontinuation: reasons, challenges, and solutions. 2015.
Jain AK. Fertility reduction and the quality of family planning services. Stud Fam Plan. 1989;20:1–16.
Blanc AK, Curtis SL, Croft TN. Monitoring contraceptive continuation: links to fertility outcomes and quality of care. Stud Fam Plan. 2002;33:127–40. https://doi.org/10.2307/3181168.
Inoue K, Barratt A, Richters J. Does research into contraceptive method discontinuation address women’s own reasons? A critical review. J Fam Plann Reprod Health Care. 2015;41:292–9. https://doi.org/10.1136/jfprhc-2014-100976.
Vitzthum VJ, Ringheim K. Hormonal contraception and physiology: a research-based theory of discontinuation due to side effects. Stud Fam Plan. 2005;36:13–32.
McCarraher DR, Martin SL, Bailey PE. The influence of method-related partner violence on covert pill use and pill discontinuation among women living in La Paz, el alto and Santa Cruz. Bolivia J Biosoc Sci. 2006;38:169–86. https://doi.org/10.1017/S0021932005025897.
Rashid S. Indigenous notions of the workings of the body: conflicts and dilemmas with Norplant use in rural Bangladesh. Qual Health Res. 2001;11:85–102.
Castle S. Factors influencing young Malians’ reluctance to use hormonal contraceptives. Stud Fam Plan. 2003:186–99.
D'Antona Ade O, Chelekis JA, D'Antona MF, Siqueira AD. Contraceptive discontinuation and non-use in Santarém, Brazilian Amazon. Cad Saude Publica. 2009;25(9):2021–32.
Ochako R, Mbondo M, Aloo S, Kaimenyi S, Thompson R, Temmerman M, et al. Barriers to modern contraceptive methods uptake among young women in Kenya: a qualitative study. BMC Public Health. 2015;15:118. https://doi.org/10.1186/s12889-015-1483-1.
Kibira SPS, Muhumuza C, Bukenya JN, Atuyambe LM. “I spent a full month bleeding, I thought I was going to die” a qualitative study of experiences of women using modern contraception in Wakiso district. PLoS One. 2015;10(11):e0141998. doi:10.1371/journal.pone.0141998. eCollection 2015.
Vitzthum VJ. The ecology and evolutionary endocrinology of reproduction in the human female. Am J Phys Anthropol. 2009;140(SUPPL. 49):95–136.
Jones RE, Lopez KH. Human reproductive biology. 2006.
Vitzthum VJ, Spielvogel H, Thornburg J. Interpopulational differences in progesterone levels during conception and implantation in humans. Proc Natl Acad Sci U S A. 2004;101:1443–8.
Harris AL, Vitzthum VJ, Harris AL. Darwin’s legacy: an evolutionary view of women’s reproductive and sexual functioning. J Sex Res. 2013;50:207–46. https://doi.org/10.1080/00224499.2012.763085.
Vitzthum VJ, Bentley GR, Spielvogel H, Caceres E, Thornburg J, Jones L, et al. Salivary progesterone levels and rate of ovulation are significantly lower in poorer than in better-off urban-dwelling Bolivian women. Hum Reprod. 2002;17:1906–13.
Núñez-De La Mora A, Chatterton RT, Choudhury OA, Napolitano DA, Bentley GR. Childhood conditions influence adult progesterone levels. PLoS Med. 2007;4:0813–21.
Banteyerga H. Ethiopia’s health extension program: improving health through community involvement. MEDICC Rev. 2011;13:46–9.
World Health Organization, Global Health Workforce Alliance. Country case study: Ethiopia’s human resources for health program. Heal (San Fr. 2008;:1–7. http://www.who.int/workforcealliance/knowledge/case_studies/Ethiopia.pdf.
Steele F, Curtis S. Appropriate methods for analyzing the effect of method choice on contraceptive discontinuation. Demography. 2003;40:1–22.
Privacy of DHS respondents. http://dhsprogram.com/What-We-Do/Protecting-the-Privacy-of-DHS-Survey-Respondents.cfm. Accessed 14 Aug 2016.
Ali M, Cleland J. Determinants of contraceptive discontinuation in six developing countries. J Biosoc Sci. 1999;31:343–60.
Bongaarts J. A framework for analyzing the proximate determinants of fertility. Popul Dev Rev. 1978;4:105. https://doi.org/10.2307/1972149.
Caldwell J, Caldwell P. High fertility in sub-Saharan Africa. Sci Am. 1990;262:82–9.
Dasgupta A, Ueffing P, Kantorova V. Patterns and trends in sexual activity by marital status and its relation to the use of contraception, analysing data from 224 demographic and health surveys and 42 multiple-indicator cluster surveys. In: Population Association of America; 2017.
Ali MM, Cleland J. Contraceptive switching after method-related discontinuation: levels and differentials. Stud Fam Plan. 2010;41:129–33.
Pankhurst H. Gender, development and identity: an Ethiopian study. London: Zed Books, Ltd; 1992.
UNFPA. Choices not chance- UNFPA family planning strategy; 2012-2020. p. 2012.
Campbell M, Sahin-Hodoglugil NN, Potts M. Barriers to fertility regulation: a review of the literature. Stud Fam Plan. 2006;37:87–98.
Diamond-Smith N, Campbell M, Madan S. Misinformation and fear of side-effects of family planning. Cult Health Sex. 2012;14:421–33.
Jasienska G, Ellison PT. Physical work causes suppression of ovarian function in women. ProcBiolSci. 1998;265:1847–51. https://doi.org/10.1098/rspb.1998.0511.
Bentley GR. Hunter-gatherer energetics and fertility: a reassessment of the !Kung san. Hum Ecol. 1985;13:79–109.
Ellison PT, Peacock NR, Lager C. Ecology and ovarian function among Lese women of the Ituri Forest, Zaire. Am J Phys Anthropol. 1989;78:519–26. https://doi.org/10.1002/ajpa.1330780407.
Panter-Brick C, Lotstein DS, Ellison PT. Seasonality of reproductive function and weight loss in rural Nepali women. Hum Reprod. 1993;8:684–90. http://humrep.oxfordjournals.org/content/8/5/684.abstract
Ali MM, Cleland JG. Contraceptive discontinuation in six developing countries: a cause-specific analysis. Int Fam Plan Perspect. 1995;21:92–7.
Curtis SL, Blanc AK. Determinants of contraceptive failure, switching, and discontinuation: an analysis of DHS contraceptive histories. DHS Analytical Reports No. 6. 1997. http://dhsprogram.com/pubs/pdf/AR6/AR6.pdf.
Ali MM, Park MH, Ngo TD. Levels and determinants of switching following intrauterine device discontinuation in 14 developing countries. Contraception. 2014;90:47–53.
Alvergne A, Lawson DW, Clarke PMR, Gurmu E, Mace R. Fertility, parental investment, and the early adoption of modern contraception in rural Ethiopia. Am J Hum Biol. 2013;25:107–15.
Worku A.G, Tessema G.A & Zeleke AA. Trends and determinants of contraceptive use among young married women (age 15–24) based on the 2000, 2005, and 2011 Ethiopian Demographic and Health Surveys: A multivariate decomposition analysis. 2014. http://dhsprogram.com/pubs/pdf/WP103/WP103.pdf.
Bledsoe C, Banja F, Hill AG. Reproductive mishaps and western contraception: an African challenge to fertility theory. Popul Dev Rev. 1998;24:15–57. https://doi.org/10.2307/2808121.
Federal Democratic Republic of Ethiopia Ministry of Health, F. Family Planning HEAT Module. The Open University; 2011. Available from www.moh.gov.et. http://www.open.edu/openlearncreate/mod/oucontent/view.php?id=133%253F.
Bentley G. Do hormonal contraceptives ignore human biological variation and evolution. Ann N Y Acad Sci. 1994;709:201–3.
Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell DR Jr. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception. 2017;70:11–8. https://doi.org/10.1016/j.contraception.2004.01.011.